Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.
暂无分享,去创建一个
C. Heldin | A. Moustakas | M. Landström | Aristidis Moustakas | Carl-Henrik Heldin | Maréne Landström
[1] A. Karsan,et al. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. , 2007, The Journal of experimental medicine.
[2] K. Venkatasubbarao,et al. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells. , 2008, Cancer research.
[3] J. Alcorn,et al. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1 , 2008, Journal of Cell Science.
[4] E. Hay,et al. TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex , 2007, Journal of Cell Science.
[5] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[6] Malte Buchholz,et al. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. , 2007, Cancer research.
[7] R. Derynck,et al. The TGF-β Family , 2008 .
[8] Takeshi Imamura,et al. Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-β* , 2009, Journal of Biological Chemistry.
[9] S. Aizawa,et al. EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial–mesenchymal transition , 2008, The Journal of cell biology.
[10] Atsushi Miyawaki,et al. Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.
[11] Liang Xie,et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.
[12] Stephen W. Michnick,et al. PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3 , 2004, Nature Cell Biology.
[13] W. Schiemann,et al. Src phosphorylates Tyr284 in tgf-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion , 2007 .
[14] M. Howell,et al. Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation , 2007, Molecular and Cellular Biology.
[15] Jonas Larsson,et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.
[16] Kohei Miyazono,et al. Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β , 2007 .
[17] G. Blobe,et al. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. , 2008, Carcinogenesis.
[18] M. Karin,et al. IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation , 2008, Proceedings of the National Academy of Sciences.
[19] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[20] Xuedong Liu,et al. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. , 2008, Genes & development.
[21] G. Wildey,et al. TGFβ‐mediated BIM expression and apoptosis are regulated through SMAD3‐dependent expression of the MAPK phosphatase MKP2 , 2008, EMBO reports.
[22] Pamela A. Hoodless,et al. Slug is a direct Notch target required for initiation of cardiac cushion cellularization , 2008, The Journal of cell biology.
[23] C. Steindler,et al. TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling , 2008 .
[24] J. Keski‐Oja,et al. Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells , 2006, Journal of Cell Science.
[25] E. Robertis,et al. Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal , 2007, Cell.
[26] N. Liberati,et al. Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling , 2008, Oncogene.
[27] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[28] W. Liu,et al. Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells. , 2008, Biochimica et biophysica acta.
[29] T. Brabletz,et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells , 2008, EMBO reports.
[30] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[31] J. Zavadil,et al. Transforming Growth Factor-β and microRNA:mRNA Regulatory Networks in Epithelial Plasticity , 2007, Cells Tissues Organs.
[32] Konstantinos J. Mavrakis,et al. Arkadia Enhances Nodal/TGF-β Signaling by Coupling Phospho-Smad2/3 Activity and Turnover , 2007, PLoS biology.
[33] R. Derynck,et al. The type I TGF-β receptor is covalently modified and regulated by sumoylation , 2008, Nature Cell Biology.
[34] M. Reiss,et al. Novel inactivating mutations of transforming growth factor‐β type I receptor gene in head‐and‐neck cancer metastases , 2001, International journal of cancer.
[35] Domenico Coppola,et al. MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.
[36] E. Bottinger,et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. , 2008, The Journal of clinical investigation.
[37] Samy Lamouille,et al. Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway , 2007, The Journal of cell biology.
[38] K. Luo,et al. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis , 2004, Nature Cell Biology.
[39] C. Heldin,et al. HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition* , 2008, Journal of Biological Chemistry.
[40] R. Randall,et al. Transforming Growth Factor (cid:2) -Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth (cid:1) † , 2022 .
[41] Liliana Attisano,et al. SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor , 1998, Cell.
[42] A. Brivanlou,et al. Balancing BMP signaling through integrated inputs into the Smad1 linker. , 2007, Molecular cell.
[43] Hui Wang,et al. Novel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation , 2006 .
[44] Luzhe Sun,et al. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. , 2008, Cancer research.
[45] Xu Cao,et al. Endofin acts as a Smad anchor for receptor activation in BMP signaling , 2007, Journal of Cell Science.
[46] D. Iliopoulos,et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.
[47] C. Heldin,et al. Notch signaling is necessary for epithelial growth arrest by TGF-β , 2007, The Journal of cell biology.
[48] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[49] C. Heldin,et al. Jcb: Report , 2022 .
[50] H. Aburatani,et al. Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. , 2007, Cancer research.
[51] M. Korpal,et al. The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2* , 2008, Journal of Biological Chemistry.
[52] M. Bissell,et al. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. , 2007, Cancer research.
[53] C. Heldin,et al. Non-Smad TGF-β signals , 2005, Journal of Cell Science.
[54] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[55] Wei He,et al. Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway , 2006, Cell.
[56] C. Heldin,et al. TGFβ1-Induced Activation of ATM and p53 Mediates Apoptosis in a Smad7-Dependent Manner , 2006, Cell cycle.
[57] M. Yamashita,et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.
[58] J. Hauser,et al. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. , 2008, Cancer research.
[59] R. Kucherlapati,et al. Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.
[60] Y. Ip,et al. Msk is required for nuclear import of TGF-β/BMP-activated Smads , 2007, The Journal of cell biology.
[61] B. Hinz,et al. Lkb1 is required for TGFβ-mediated myofibroblast differentiation , 2008, Journal of Cell Science.
[62] H. Huber,et al. PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression , 2007, Oncogene.
[63] C. Heldin,et al. Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.
[64] Konstantinos J. Mavrakis,et al. Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-β Signaling* , 2007, Journal of Biological Chemistry.
[65] C. Heldin,et al. Smad signal transduction : Smads in proliferation, differentiation and disease , 2006 .
[66] Brian Bierie,et al. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.
[67] Tomoki Chiba,et al. Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.
[68] Hui Wang,et al. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. , 2008, Cancer research.
[69] D. C. Clarke,et al. Activation of Mps1 Promotes Transforming Growth Factor-β-independent Smad Signaling* , 2007, Journal of Biological Chemistry.
[70] B. Olsen,et al. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.
[71] C. Heldin,et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.
[72] R. Bernards,et al. Transforming Growth Factor-β Requires Its Target Plasminogen Activator Inhibitor-1 for Cytostatic Activity* , 2008, Journal of Biological Chemistry.
[73] Alicia Zhou,et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers , 2007, Proceedings of the National Academy of Sciences.
[74] Andrew J Link,et al. A proximal activator of transcription in epithelial-mesenchymal transition. , 2007, The Journal of clinical investigation.
[75] J. Wrana,et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.
[76] S. Vukicevic,et al. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. , 2007, Cancer research.
[77] M. Yaffe,et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal , 2008, Nature Cell Biology.
[78] A. Hinck,et al. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.
[79] C. Heldin,et al. The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.
[80] Jean Paul Thiery,et al. Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.
[81] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[82] U. Lendahl,et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.
[83] C. Heldin,et al. Smad Signal Transduction , 2006 .
[84] Y. Khew-Goodall,et al. The protein tyrosine phosphatase Pez regulates TGFβ, epithelial–mesenchymal transition, and organ development , 2007, The Journal of cell biology.
[85] K. Friedrich,et al. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. , 2008, Cancer research.
[86] P. Dijke,et al. Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .
[87] W. Kwiatkowski,et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.
[88] C. Heldin,et al. Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.
[89] T. Morita,et al. Dual roles of myocardin-related transcription factors in epithelial–mesenchymal transition via slug induction and actin remodeling , 2007, The Journal of cell biology.
[90] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[91] A. Roberts,et al. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. , 1998, Genes & development.
[92] Yue Zhang,et al. Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity , 2005, Science.
[93] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[94] L. Alphey,et al. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster , 2002, Nature Genetics.
[95] J. Lasky,et al. Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition* , 2008, Journal of Biological Chemistry.
[96] Xin-Hua Feng,et al. Microtubule Binding to Smads May Regulate TGFβ Activity , 2000 .
[97] Paul A. Bates,et al. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system , 2008, Proceedings of the National Academy of Sciences.
[98] E. Guccione,et al. A positive role for Myc in TGFβ-induced Snail transcription and epithelial-to-mesenchymal transition , 2009, Oncogene.
[99] Zhi Wang,et al. Endofin, a FYVE Domain Protein, Interacts with Smad4 and Facilitates Transforming Growth Factor-β Signaling* , 2007, Journal of Biological Chemistry.
[100] Kohei Miyazono,et al. Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells , 2008, Journal of Cell Science.
[101] M. Jackson,et al. Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression , 2008, Oncogene.
[102] T. Sjöblom,et al. Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis , 2007, Oncogene.
[103] A. Puisieux,et al. Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.
[104] R. Assoian,et al. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition. , 2008, Cancer research.
[105] William P Schiemann,et al. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. , 2008, Carcinogenesis.
[106] Jing Qing,et al. TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .